Isingeniso Esizindeni se-oncology, i-immunotherapy isivele njengendlela yokuqala, esebenzisa amasosha omzimba ukuze alwe nezimila eziyingozi. Kunezindlela eziningi ze-immunotherapeutic, kepha i-Chimeric Antigen Rece.
Juni 2022: Ngemva kwemigqa emibili noma ngaphezulu yokwelashwa kwe-systemic, i-FDA yaklomelisa i-tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) yagunyaza ngokushesha iziguli ezikhulile ezine-lymphoma ebuyelelwe emuva noma e-refractory follicular (FL).T..
Mashi 2022: Indlela eguquguqukayo yokwelashwa kwe-CAR-T Cell inamandla okugumbuqela lokho osekuyi-axiom yezokwelapha: ukuthi umphumela omangalisayo wokwelashwa kumathumba ufika ngenani lezingozi ezinkulu ezigulini.
I-Immunotherapy ekwelapheni umdlavuzaUkwelashwa kwe-CAR-NK kunesilinganiso esisebenzayo esingu-73%, futhi kuqashwa ezivivinyweni zomtholampilo zasekhaya.I-Immunotherapy iguqule indlela olashwa ngayo umdlavuza. I-Cancer immunotherapy ihlukaniswe..
Julayi 2021: Hlola izidakamizwa zakamuva ekwelapheni umdlavuza. Minyaka yonke, ngemva kokuhlola izivivinyo nezinye izici ezibalulekile, i-USFDA ivuma izidakamizwa, futhi ngaleyo ndlela iziguli ezinomdlavuza manje zingakholwa ukuthi ikhambi seliseduze kakhulu. ..